Can B (CANB) 10-Q 19 Aug 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2020	Aug. 14, 2020
Cover [Abstract]
Entity Registrant Name	Can B Corp
Entity Central Index Key	0001509957
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		3,840,053
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 390,201	$ 46,540
Accounts receivable, less allowance for doubtful accounts of $385,468 and $0, respectively	1,496,836	1,251,609
Inventory	373,833	784,497
Note Receivable	23,787	24,268
Deposit - current	312,655
Prepaid expenses - current	1,259,604	1,279,901
Total current assets	3,856,916	3,386,815
Property and equipment, at cost less accumulated depreciation of $178,065 and $116,555, respectively	1,030,519	1,075,242
Other assets:
Deposit - noncurrent	21,287	21,287
Prepaid expenses - noncurrent	591,819	1,179,929
Other receivable - noncurrent	23,581	58,206
Intangible assets, net of accumulated amortization of $479,679 and $202,521, respectively	980,591	1,056,562
Investment in Marketable Securities	550,000
Goodwill	55,849	55,849
Right-of-Use Asset, net of amortization of $25,208 and $6,280, respectively	78,052	96,980
Total other assets	2,301,179	2,468,813
Total assets	7,188,614	6,930,870
Current liabilities:
Accounts payable	377,307	226,467
Accrued officers' compensation	240,410	144,363
Other accrued expenses payable	28,886	61,557
Notes and loans payable	1,164,138	35,000
Current portion of lease liability	40,941	38,281
Total current liabilities	1,851,682	505,668
Long-term liabilities:
Non-current portion of lease liability	37,786	58,998
Notes and loans payable	354,840
Total long-term liabilities	392,626	58,998
Total liabilities	2,244,308	564,666
Commitments and contingencies (Notes 15)
Stockholders' equity:
Common stock, no par value; authorized 1,500,000,000 shares, issued and outstanding 3,421,338 and 2,680,937 shares, respectively	24,056,211	23,113,077
Additional Paid-in capital	872,976	872,976
Additional Paid-in capital - Stock Options (Note 12)	202,200	202,200
Accumulated deficit	(25,726,255)	(23,361,223)
Total stockholders' equity	4,944,306	6,366,204
Total liabilities and stockholders' equity	7,188,614	6,930,870
Series A Preferred Stock [Member]
Stockholders' equity:
Preferred stock, authorized 5,000,000 shares:	$ 5,539,174	$ 5,539,174

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Allowance for doubtful accounts	$ 385,468	$ 0
Accumulated depreciation, property and equipment	178,065	116,555
Amortization of intangible assets	479,679	202,521
Amortization of right-of-use Asset	$ 25,208	$ 6,280
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock, par value
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	3,421,338	2,680,937
Common stock, shares outstanding	3,421,338	2,680,937
Series A Preferred Stock [Member]
Preferred stock, shares authorized	20	20
Preferred stock, par value
Preferred stock, shares issued	20	20
Preferred stock, shares outstanding	20	20

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues
Total Revenues	$ 205,084	$ 633,579	$ 774,791	$ 1,150,739
Cost of product sales	48,045	299,204	169,594	561,757
Gross Profit	157,039	334,375	605,197	588,982
Operating costs and expenses:
Officers and director's compensation (including stock-based compensation of $622,671, $834,230, $30,000 and $336,882, respectively)	382,082	829,138	1,020,755	1,274,688
Consulting fees (including stock-based compensation of $353,116, $953,914, $181,764 and $388,138, respectively)	206,614	427,335	423,022	1,091,086
Advertising expense	141,205	127,374	260,035	153,762
Hosting expense	5,793	7,467	12,136	7,917
Rent expense	29,046	484	121,652	12,344
Professional fees	134,958	74,180	325,136	112,016
Depreciation of property and equipment	4,008	11,532	8,103	14,297
Amortization of intangible assets	147,192	4,966	277,158	7,160
Reimbursed Expenses	20,674	35,474	40,963	62,776
Other	204,940	251,714	347,703	460,293
Total operating expenses	1,276,512	1,769,664	2,836,663	3,196,339
Loss from operations	(1,119,473)	(1,435,289)	(2,231,466)	(2,607,357)
Other income (expense):
Interest income	221	317	441	317
Interest expense (including amortized finance cost of $69,645 $0, $58,967 and $0, respectively)	(68,898)	(2,519)	(82,782)	(2,965)
Other income (expense) - net	(68,677)	(2,202)	(82,341)	(2,648)
Loss before provision for income taxes	(1,188,150)	(1,437,491)	(2,313,807)	(2,610,005)
Provision for income taxes	275		1,225
Net Loss	$ (1,188,425)	$ (1,437,491)	$ (2,315,032)	$ (2,610,005)
Net loss per common share - basic	$ (0.39)	$ (0.76)	$ (0.79)	$ (1.47)
Net loss per common share - diluted	$ (0.32)	$ (0.6)	$ (0.64)	$ (1)
Weighted average common shares outstanding -
Basic	3,079,235	1,880,137	2,947,930	1,776,620
Diluted	3,745,915	2,384,289	3,614,610	2,603,610
Product Sales [Member]
Revenues
Total Revenues	$ 204,684	$ 631,779	$ 774,091	$ 1,147,139
Service Revenue [Member]
Revenues
Total Revenues	$ 400	$ 1,800	$ 700	$ 3,600

Consolidated Statements of Op_2

Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Stock-based compensation			$ 975,787	$ 1,788,144
Amortization of debt discounts	$ 58,967	$ 0	69,645
Consulting Fees [Member]
Stock-based compensation	181,764	388,138	353,116	953,914
Officers and Directors [Member]
Stock-based compensation	$ 30,000	$ 336,882	$ 622,671	$ 834,230

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Net Loss	$ (1,188,425)	$ (1,437,491)	$ (2,315,032)	$ (2,610,005)
Other comprehensive loss:
Unrealized loss on marketable securities	(42,500)		(50,000)
Comprehensive Loss	$ (1,230,925)	$ (1,437,491)	$ (2,365,032)	$ (2,610,005)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficiency (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Preferred Stock A [Member]
Balance			$ 5,539,174	$ 4,557,424
Balance, shares			20	18
Issuance of Series A Preferred stock pursuant to employment agreement				$ 992,250
Issuance of Series A Preferred stock pursuant to employment agreement, shares				3
Issuance of common stock for retirement of Series A preferred stock				$ (10,500)
Issuance of common stock for retirement of Series A preferred stock, shares				(1)
Net loss
Balance	$ 5,539,174	$ 5,539,174	$ 5,539,174	$ 5,539,174
Balance, shares	20	20	20	20
Preferred Stock B [Member]
Balance				$ 479
Balance, shares				499,958
Issuance of common stock for retirement of Series B preferred stock				$ (157)
Issuance of common stock for retirement of Series B preferred stock, shares				(157,105)
Net loss
Balance		$ 322		$ 322
Balance, shares		342,853		342,853
Preferred Stock C [Member]
Balance
Balance, shares
Net loss
Balance
Balance, shares
Common Stock [Member]
Balance			$ 23,113,077	$ 16,624,557
Balance, shares			2,680,937	1,468,554
Issuance of common stock for retirement of Series A preferred stock				$ 10,500
Issuance of common stock for retirement of Series A preferred stock, shares				33,333
Issuance of common stock for retirement of Series B preferred stock				$ 157
Issuance of common stock for retirement of Series B preferred stock, shares				67,405
Sale of common stock in 2019				$ 1,946,100
Sale of common stock in 2019, shares				224,314
Issuance of common stock in 2019 for acquisition of technology				$ 148,655
Issuance of common stock in 2019 for acquisition of technology, shares				28,333
Issuance of common stock in 2019 for satisfaction of accrued salaries				$ 54,340
Issuance of common stock in 2019 for satisfaction of accrued salaries, shares				2,227
Issuance of common stock in 2019 for compensation and services rendered				$ 1,156,944
Issuance of common stock in 2019 for compensation and services rendered, shares				159,737
Issuance of common stock in 2020 for services rendered			$ 315,615
Issuance of common stock in 2020 for services rendered, shares			190,888
Issuance of common stock in 2020 for 300:1 reverse stock split rounding
Issuance of common stock in 2020 for 300:1 reverse stock split rounding, shares			2,460
Issuance of common stock in 2020 in pursuant to First Fire note agreement			$ 295,780
Issuance of common stock in 2020 in pursuant to First Fire note agreement, shares			119,508
Issuance of common stock in 2020 pursuant to Labrys Fund Equities note agreement			$ 80,182
Issuance of common stock in 2020 pursuant to Labrys Fund Equities note agreement shares			142,545
Issuance of common stock in 2020 pursuant to Eagle Equities note agreement			$ 8,745
Issuance of common stock in 2020 pursuant to Eagle Equities note agreement, shares			20,000
Issuance of common stock in 2020 for acquisition of intangible assets			$ 201,187
Issuance of common stock in 2020 for acquisition of intangible assets Shares			235,000
Issuance of common stock in 2020 for compensation			$ 41,625
Issuance of common stock in 2020 for compensation, Shares			30,000
Net loss
Balance	$ 24,056,211	$ 19,941,253	$ 24,056,211	$ 19,941,253
Balance, shares	3,421,338	1,983,903	3,421,338	1,983,903
Additional Paid-in Capital [Member]
Balance			$ 1,075,176	$ 1,075,176
Net loss
Balance	$ 1,075,176	$ 1,075,176	1,075,176	1,075,176
Accumulated Deficit [Member]
Balance			(23,361,223)	(18,786,753)
Net loss			(2,315,032)	(2,610,005)
Other comprehensive loss			(50,000)
Balance	(25,726,255)	(21,378,758)	(25,726,255)	(21,378,758)
Balance			6,366,204	3,488,883
Issuance of Series A Preferred stock pursuant to employment agreement				992,250
Issuance of common stock for retirement of Series A preferred stock
Issuance of common stock for retirement of Series B preferred stock
Sale of common stock in 2019				1,946,100
Issuance of common stock in 2019 for acquisition of technology				148,655
Issuance of common stock in 2019 for satisfaction of accrued salaries				54,340
Issuance of common stock in 2019 for compensation and services rendered				1,156,944
Issuance of common stock in 2020 for services rendered			315,615
Issuance of common stock in 2020 for 300:1 reverse stock split rounding
Issuance of common stock in 2020 in pursuant to First Fire note agreement			295,780
Issuance of common stock in 2020 pursuant to Labrys Fund Equities note agreement			80,182
Issuance of common stock in 2020 pursuant to Eagle Equities note agreement			8,745
Issuance of common stock in 2020 for acquisition of intangible assets			201,187
Issuance of common stock in 2020 for compensation			41,625
Net loss			(2,315,032)	(2,610,005)
Other comprehensive loss	(42,500)		(50,000)
Balance	$ 4,944,306	$ 6,366,204	$ 4,944,306	$ 6,366,204

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Deficiency (Unaudited) (Parenthetical)	Mar. 06, 2020	Mar. 02, 2020	Jun. 04, 2013	Jun. 30, 2020
Statement of Stockholders' Equity [Abstract]
Reverse stock, description	300:1 reverse split	300-to-1 reverse stock split	1 for 10 reverse stock split	300:1 reverse stock split rounding

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating Activities:
Net loss	$ (2,315,032)	$ (2,610,005)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation, net of prepaid stock-based consulting fees	975,787	1,788,144
Depreciation of property and equipment-General	8,103	14,297
Depreciation of property and equipment-COGS	53,407	24,973
Amortization of intangible assets	277,158	7,160
Amortization of original-issue-discount	69,645
Bad debt expense	131,985
Changes in operating assets and liabilities:
Accounts receivable	(377,212)	(549,388)
Inventory	410,664	(750)
Prepaid expenses	(10,140)	(7,850)
Security deposit		28,940
Other receivable	34,625	(20,225)
Right-of-use asset	376	(7,457)
Accounts payable	150,840	18,076
Accrued officer's compensation	96,047
Other accrued expenses payable	(32,671)	(10,601)
Net cash used in operating activities	(526,418)	(1,324,687)
Investing Activities:
Note receivable	481
Fixed assets additions	(16,787)	(962,698)
Intangible assets additions		(50,000)
Investment in marketable security	(600,000)
Net cash used in investing activities	(616,306)	(1,012,698)
Financing Activities:
Proceeds received from notes and loans payable	1,657,840
Repayments of notes and loans payable	(70,000)	(3,364)
Note payable finance cost	(101,455)
Proceeds from sale of common stock		1,946,100
Net cash provided by financing activities	1,486,385	1,942,736
Increase (Decrease) in cash and cash equivalents	343,661	(394,649)
Cash and cash equivalents, beginning of period	46,540	807,747
Cash and cash equivalents, end of period	390,201	413,098
SUPPLEMENTAL CASH FLOW INFORMATION:
Income taxes paid	1,225
Interest paid	13,137
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock in acquisition of note payable (returnable shares)	312,655
Issuance of common stock in acquisition of note payable (commitment shares)	72,052
Amortization of prepaid issuance of common Stock for services rendered	618,547	497,220
Issuance of common stock in acquisition of intangible assets	201,187	148,635
Issuance of common stock in satisfaction of officer's compensation		$ 54,340

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	NOTE 1 – Organization and Description of Business Can B̅ Corp. was originally incorporated as WrapMail, Inc. (“WRAP”) in Florida on October 11, 2005. Effective January 5, 2015, WRAP acquired 100% ownership of Prosperity Systems, Inc. (“Prosperity”), a New York corporation incorporated on April 2, 2008. The Company is in the process of dissolving Prosperity. The Company acquired 100% of the membership interests in Pure Health Products, LLC, a New York limited liability company (“PHP” or “Pure Health Products”) effective December 28, 2018. The Company’s durable equipment products, such as sam® units with CBD infused pads, are marketed and sold through its wholly-owned subsidiaries, Duramed Inc. (incorporated on November 29, 2018) and DuramedNJ LLC (incorporated on May 29, 2019) (collectively, “Duramed”). Duramed began operating on or about February1, 2019. The Company’s wholly owned subsidiary, Radical Tactical LLC (“Radical Tactical”), formed May 11, 2019, provides the marketplace with millennium targeted product lines such as vapes, gums, and kratom. The Company’s hemp aggregation business is run through NY Hemp Depot LLC (the “Hemp Depot”), which was formed on or around July 11, 2019. The Company’s hemp farming business is run through Green Grow Farms, Inc. (“Green Grow Farms”), which was acquired in August, 2019. Effective December 27, 2010, WRAP effected a 10-for-1 forward stock split of its common stock. Effective June 4, 2013, WRAP effected a 1-for-10 reverse stock split of its common stock. Effective March 6, 2020 Can B̅ Corp effected a 300:1 reverse stock split of its common stock. On May 15, 2017, WRAP changed its name to Canbiola, Inc. On January 16, 2020 Canbiola, Inc. changed its name to Can B̅ Corp. (the “Company”, “we”, “us”, “our”, “CANB”, “Can B̅” or “Registrant”). Can B̅ specializes in the production and sale of a variety of hemp-derived cannabidiol (“CBD”) products such as oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates. Can B̅ is developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the hemp industry. Can B̅ aims to be the premier provider of the highest quality hemp CBD products on the market through sourcing the very best raw material and developing a variety of products we believe will improve people’s lives in a variety of areas. For the periods presented, the assets, liabilities, revenues, and expenses are those of CANB. Prosperity, Radical Tactical and NY Hemp Depot had no activity for the periods presented. Financial information for PHP, Duramed and Green Grow Farms in the periods have been consolidated with the Company’s financials.

Going Concern Uncertainty

Going Concern Uncertainty	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern Uncertainty	NOTE 2 – Going Concern Uncertainty The consolidated financial statements have been prepared on a “going concern” basis, which contemplates the realization of assets and liquidation of liabilities in a normal course of business. As of June 30, 2020, the Company had cash and cash equivalents of $390,201 and a working capital of $2,005,234. For the periods ended June 30, 2020 and 2019, the Company had net loss of $2,365,032 and $2,610,005, respectively. These factors raise substantial doubt as to the Company’s ability to continue as a going concern. The Company plans to improve its financial condition by raising capital through sales of shares of its common stock. Also, the Company plans to expand its operation of CBD products to increase its profitability. The consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies (a) Principles of Consolidation The consolidated financial statements include the accounts of CANB and its wholly-owned subsidiaries, Pure Health Products, Duramed, Prosperity Radical Tactical and Green Grow Farms. All intercompany balances and transactions have been eliminated in consolidation. (b) Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. (c) Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, notes receivable, notes and loans payable, accounts payable, and accrued expenses payable. Except for the noncurrent note receivable, the fair value of these financial instruments approximate their carrying amounts reported in the balance sheets due to the short term maturity of these instruments. Based on comparable instruments with similar terms, the fair value of the noncurrent note receivable approximates its carrying value. Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. (d) Cash and Cash Equivalents The Company considers all liquid investments purchased with a maturity of three months or less to be cash equivalents. (e) Accounts receivable Accounts receivable are presented in the balance sheet net of the allowance for doubtful accounts. Accounts receivable are written off when they are determined to be uncollectible. The allowance for doubtful accounts is estimated based on the Company’s historical losses, the existing economic conditions in the industry, and the financial stability of its customers. Bad debt expense was $131,985 and $0 for the periods ended June 30, 2020 and 2019. (f) Inventory Inventories consist of raw materials and finished goods and are stated at the lower of cost or net realizable value. Cost is principally determined using the first-in, first-out (FIFO) method. (g) Prepaid expenses Prepaid expenses include stock-based officer, employee and consulting compensation of $1,836,523 and $3,226,390 at June 30, 2020 and 2019, respectively. The Company’s policy is to record stock-based compensation as prepaids and expense over the term of employment and consulting agreements. (h) Property and Equipment, Net Property and equipment, net, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs are charged to operations as incurred. (i) Intangible Assets, Net Intangible assets, net, are stated at cost less accumulated amortization. Amortization is calculated using the straight-line method over the estimated economic lives of the respective assets. (j) Marketable Securities Marketable securities are recorded at fair value with unrealized gains and losses included in income. The Company has classified its investments in 1,000,000 shares of Iconic Brands, Inc. as trading securities. (k) Goodwill The Company does not amortize goodwill, but instead tests for impairment at least annually. When conducting the annual impairment test for goodwill, the Company compares the estimated fair value of a reporting unit containing goodwill to its carrying value. If the estimated fair value of the reporting unit is determined to be less than its carrying value, goodwill is reduced, and an impairment loss is recorded. (l) Long-lived Assets The Company reviews long-lived assets held and used, intangible assets with finite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset is compared to the asset’s carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value. (m) Revenue Recognition The Company recognizes revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which requires that five basic steps be followed to recognize revenue: (1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the performance obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration given, whether that control happens over time or not. Determination of criteria (3) and (4) are based on our management’s judgments regarding the fixed nature of the selling prices of the products and services delivered and the collectability of those amounts. Private Label Customers, Global CBD, LLC and TZ Wholesale, are wholesale distributors of the Company’s product, under their own wholesale private label brand. The products are made to Company specifications and shipped directly to the wholesaler. The pricing is predicated upon a volume discount negotiated at the time of the placement of the orders. Product is produced and labeled in the Washington manufacturing facility and shipped directly to the Private Label customer who re-distributes to their retail and other customers. The products are fully paid when shipped. Revenue from product sales is recognized when an order has been obtained, the price is fixed and determinable, the product is shipped, title has transferred, and collectability is reasonably assured. The Company’s Duramed Division provides a sam® Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients’ needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient who signs a rental form, for a 35 day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The insurance company pays the invoice, or a negotiated amount via arbitration, and that revenue is reported as revenue when invoiced to the insurance carrier. The collected amount is reconciled with the invoice amount on a daily basis. (n) Cost of Product Sales The cost of product sale is the total cost incurred to obtain a sale and the cost of the goods sold, and the Company’s policy is to recognize it in the same manner as, and in conjunction with, revenue recognition. Cost of product sale primarily consisted of the costs directly attributable to revenue recognized and includes expenses related to the production, packaging and labeling of our CBD products. (o) Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation – Stock Compensation” (“ASC718”) and ASC 505-50, “Equity – Based Payments to Non-Employees.” In addition to requiring supplemental disclosures, ASC 718 addresses the accounting for share-based payment transactions in which a company receives goods or services in exchange for (a) equity instruments of the company or (b) liabilities that are based on the fair value of the company’s equity instruments or that may be settled by the issuance of such equity instruments. ASC 718 focuses primarily on accounting for transactions in which a company obtains employee services in share-based payment transactions. In accordance with ASC 505-50, the Company determines the fair value of the stock-based payment as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. If the fair value of the equity instruments issued is used, it is measured using the stock price and other measurement assumptions as of the earlier of either (1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached, or (2) the date at which the counterparty’s performance is complete. Options and warrants The fair value of stock options and warrants is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year: Risk-Free Interest Rate. We utilized the U.S. Treasury yield curve in effect at the time of grant with a term consistent with the expected term of our awards. Expected Volatility. We calculate the expected volatility based on a volatility index of peer companies as we did not have sufficient historical market information to estimate the volatility of our own stock. Dividend Yield. We have not declared a dividend on its common stock since its inception and have no intentions of declaring a dividend in the foreseeable future and therefore used a dividend yield of zero. Expected Term. The expected term of options granted represents the period of time that options are expected to be outstanding. We estimated the expected term of stock options by using the simplified method. For warrants, the expected term represents the actual term of the warrant. Forfeitures. Estimates of option forfeitures are based on our experience. We will adjust our estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods. (p) Advertising Advertising costs are expensed as incurred and amounted to $260,035 and $153,762 for the periods ended June 30, 2020 and 2019, respectively. (q) Research and Development Research and development costs are expensed as incurred. In the period ended June 30, 2020 and 2019, the Company spent $25,000 and $70,000 in research and development which was expenses as spent, respectively. (r) Income Taxes Income taxes are accounted for under the assets and liability method. Current income taxes are provided in accordance with the laws of the respective taxing authorities. Deferred income taxes are provided for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is not more likely than not that some portion or all of the deferred tax assets will be realized. The Company has adopted the provisions required by the Income Taxes topic of the FASB Accounting Standards Codification. The Codification Topic requires the recognition of potential liabilities as a result of management’s acceptance of potentially uncertain positions for income tax treatment on a “more-likely-than-not” probability of an assessment upon examination by a respective taxing authority. The Company believes that it has not taken any uncertain tax positions and thus has not recorded any liability. (s) Net Income (Loss) per Common Share Basic net income (loss) per common share is computed on the basis of the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is computed on the basis of the weighted average number of common shares and dilutive securities (such as stock options and convertible securities) outstanding. Dilutive securities having an anti-dilutive effect on diluted net income (loss) per share are excluded from the calculation. For the periods presented, the diluted net loss per share calculation excluded the effect of Series B preferred stocks and stock options outstanding (see Notes 10, 11 and 12). (t) Reverse Stock-Split On March 2, 2020, the Company filed an amendment to its Articles of Incorporation with the Florida Secretary of State to effect a 300-to-1 reverse stock split of its issued and outstanding, but not authorized, shares of Common Stock, as reported in the Company’s definitive Schedule 14C filed with the Securities and Exchange Commission on December 13, 2019. All disclosures of common shares and per common share data in the accompanying financial statements and related notes reflect the reverse stock split for all periods presented. (u) Recent Accounting Pronouncements In 2016, the FASB issued ASU 2016-2 (Topic 842) which establishes a new lease accounting model for lessees. Under the new guidance, lessees will be required to recognize right of use assets and liabilities for most leases having terms of 12 months or more. Effective January 1, 2019, we adopted this new accounting guidance using the effective date transition method, which permits entities to apply the new lease standards using a modified retrospective transition approach at the date of adoption. (v) Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six-month period ended June 30, 2020 are not necessarily indicative of the results that may be expected for the year ended December 31, 2020. (w) Reclassifications Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation. These reclassification adjustments had no effect on the Company’s previously reported net income.

Inventories

Inventories	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Inventories	NOTE 4 – Inventories Inventories consist of: June 30, December 31, Raw materials $ 359,213 $ 708,239 Finished goods 14,620 76,258 Total $ 373,833 $ 784,497

Notes Receivable

Notes Receivable	6 Months Ended
	Jun. 30, 2020
Receivables [Abstract]
Notes Receivable	NOTE 5 – Notes Receivable Notes receivable consist of: June 30, December 31, Note receivable dated November 30, 2015 from Stock Market Manager, Inc, interest at 3% per annum due November 30, 2020 $ 19,389 $ 19,389 Note receivable dated February 8, 2019 from an employee, weekly installments of $1,200 with interest at 8% per annum. 2,898 4,879 Note receivable dated March 3, 2020 from an employee, weekly installments of $125 with interest at 0% per annum. 1,500 - Total 23,787 24,268 Current portion of notes receivable (23,787 ) (24,268 ) Noncurrent portion of notes receivable $ - $ -

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	NOTE 6 – Property and Equipment, Net Property and Equipment, net, consist of: June 30, December 31, 2020 2019 Furniture & Fixtures $ 21,724 $ 19,018 Office Equipment 12,378 12,378 Manufacturing Equipment 363,798 355,016 Medical Equipment 783,782 783,782 Leasehold Improvements 26,902 21,603 Total 1,208,584 1,191,797 Accumulated depreciation (178,065 ) (116,555 ) Net $ 1,030,519 $ 1,075,242

Intangible Assets, Net

Intangible Assets, Net	6 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	NOTE 7 – Intangible Assets, Net Intangible assets, net, consist of: June 30, December 31, 2020 2019 Video conferencing software acquired by Prosperity in December 2009 $ 30,000 $ 30,000 Enterprise and audit software acquired by Prosperity in April 2008 20,000 20,000 Patent costs incurred by WRAP 6,880 6,880 Hemp license and technology 1,000,000 1,000,000 CBD technology 198,655 198,655 Platform account contract 131,812 - Hemp processing use 69,375 - Other 3,548 3,548 Total 1,460,270 1,259,083 Accumulated amortization and Impairment (479,679 ) (202,521 ) Net $ 980,591 $ 1,056,562 The CBD related technology were purchased from Hudilab, Inc. (“HUDI”) and Seven Chakras, LLC (“Seven Chakras”) during the three months ended March 31, 2019. On January 14, 2019, the Company and PHP (collectively, the “buyer”) entered into a License and Acquisition Agreement (the “LAA”) with HUDI. Pursuant to the LAA, HUDI will sell the technology owned by it to the buyer in exchange for 25,000 shares of CANB common stock. On January 14, 2019, the shares were issued to the owner of HUDI and valued at $131,625. On January 31, 2019, PHP entered into an Asset Purchase Agreement (the “Chakras Agreement”) with Seven Chakras. Pursuant to the Chakras Agreement, PHP purchased the rights and title to (i) Seven Chakras’ proprietary formulas, methods, trade secrets, and know-how related to the production of Seven Chakras’ products containing cannabidiol (CBD), (ii) Seven Chakras’ tradename, domain name, and social media sites, and (iii) other assets of Seven Chakras including but not limited to raw materials, equipment, packaging and labeling materials, mailing lists, and marketing materials. On February 20, 2019, the Company issued 3,333 shares of CANB common stock valued at $17,030 to owners of Seven Chakras as additional consideration, along with the $50,000 cash payments, pursuant to the Chakras Agreement. The hemp related license and technology was purchased from Shi Farms during the three months ended September 30, 2019. Hemp Depot has been amalgamated with Green Grow Farms, also a NY State Hemp License holder and intends to contract with farmers in New York to grow hemp under a controlled program of specific strains, cultured feminized seeds, proven technology, and access to processing for their crop. NY Hemp Depot under Green Grow Farms Inc.’s direction will amalgamate the cultivated off-take from the farmers, combine and fill “super-sacks” for shipping to a processing facility to produce high-grade isolate or distillate for use in Can B̅’s manufacturing facility in Lacey WA. The hemp processing use agreement with Mediiusa Group, Inc. was entered during the three months ended June 30, 2020. On June 23, 2020, the Company issued 50,000 shares of CANB common stock valued at $69,375. Mediiusa Group, Inc. currently holds a valid Industrial Hemp Processor Registration in full force and effect with the State of New York under Registration: HEMP-P-000035 (the “Registration”) and is authorized to process Hemp, and has granted a five year agreement to processing of Hemp for oil, isolate, or crude for further use by the Company and/or for sale by the Company. During the Term of this Agreement, Mediiusa Group, Inc. agrees to allow CANB to process any and all of the subject Hemp under and/or in connection with the agreement under their above-mentioned Registration. The platform account contract with SRAX, Inc. was entered during the three months ended June 30, 2020. On June 22, 2020, the Company issued 185,000 shares of CANB common stock valued at $131,812. The Platform Account is the SRAX Investors Relations platform to grant access to potential investors and customers via the SRAX website. SRAX grants Can B Corp a non-exclusive, non-transferable and non- sublicensable right to access and use the Platform during the Term, solely by the Authorized Users for User’s own internal business purposes, and in accordance with the terms and conditions of this Agreement. Company reserves all rights in or to the Platform not expressly granted to User in the Agreement. Can B will have previously unattainable access to its customer base for improved investor communication and development of sales opportunities of the Company’s products. The other intangible assets relate to the document management and email marketing divisions. Since December 31, 2017, the Company do not expect any future positive cash flow from these divisions. Accordingly, the net carrying value of these intangible assets was reduced to $0.

Marketable Securities

Marketable Securities	6 Months Ended
	Jun. 30, 2020
Cash and Cash Equivalents [Abstract]
Marketable Securities	NOTE 8 – Marketable Securities Marketable securities consist of: June 30, December 31, Marketable securities, at cost $ 600,000 $ - Unrealized losses (50,000 ) - Total marketable securities at fair value $ 550,000 $ -

Notes and Loans Payable

Notes and Loans Payable	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Notes and Loans Payable	NOTE 9 – Notes and Loans Payable Notes and loans payable consist of: June 30, December 31, Note payable to brother of Marco Alfonsi, Chief Executive Officer of the Company, interest at 10% per annum, due August 22, 2016 (now past due) $ 5,000 $ 5,000 Note payable to FirstFire Global Opportunities Fund, LLC, net of original issue discount of $44,654, due September 1, 2020. 550,000 - Loan payable to Pasquale Ferro, interest at 12% per annum, due December 2020. 153,000 30,000 Note payable to Labrys Fund, LP, net of original issue discount of $21,041, due October 21, 2020. 225,000 - Note payable to EMA Financial, LLC, net of original issue discount of $10,522, due June 17, 2021. 115,000 - Note payable to Eagle Equities, LLC, net of original issue discount of $27,645, due June 17, 2021. 220,000 - Note payable to U.S. Small Business Administration (PPP), interest at 1% per annum. The note matures in May 2022. Payments are deferred for six months. 194,940 - Note payable to U.S. Small Business Administration (EIDL), interest at 3.75% per annum. The note matures in June 2050. Payments are deferred for twelve months. 159,900 - Total Notes and Loans Payable 1,622,840 35,000 Less: Unamortized Finance Cost (103,862 ) - Total Notes and Loans Payable - Net 1,518,978 35,000 Less: Current Portion (1,164,138 ) (35,000 ) Long-term Portion $ 354,840 $ -

Preferred Stock

Preferred Stock	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Preferred Stock	NOTE 10 – Preferred Stock Each share of Series A Preferred Stock is convertible into 33,334 shares of CANB common stock and is entitled to 66,666 votes. Each share of Series B Preferred Stock has the first preference to dividends, distributions and payments upon liquidation, dissolution and winding-up of the Company, and is entitled to an accrued cumulative but not compounding dividend at the rate of 5% per annum whether or not declared. After six months of the issuance date, such share and any accrued but unpaid dividends can be converted into common stock at the conversion price which is the lower of (i) $0.0101; or (ii) the lower of the dollar volume weighted average price of CANB common stock on the trading day prior to the conversion day or the dollar volume weighted average price of CANB common stock on the conversion day. The shares of Series B Preferred Stock have no voting rights. Each share of Series C Preferred Stock has preference to payment of dividends, if and when declared by the Company, compared to shares of our common stock. Each Preferred Series C share is convertible into 25,000 shares of common stock. The shares of Series C Preferred Stock have voting rights as if fully converted. On January 28, 2019, the Company issued 33,333 shares of CANB common stock to a consultant of the Company in exchange for the retirement of 1 share of CANB Series A Preferred Stock. From February 21, 2019 to March 12, 2019, the Company issued aggregately 67,405 shares of CANB common stock to RedDiamond in exchange for the retirement of 157,105 shares of CANB Series B Preferred Stock. On May 28, 2019, the Company issued 3 shares of CANB Series A Preferred Stock to Stanley L. Teeple pursuant to the employment agreement with him. The fair value of the issuance totaled at $1,203,000 and will be amortized over the vesting period of four years. On April 26, 2019, the Company issued 6,436 shares of CANB common stock to RedDiamond in exchange for the retirement of 15,000 shares of CANB Series B Preferred Stock. On May 1, 2019, the Company issued 8,581 shares of CANB common stock to RedDiamond in exchange for the retirement of 20,000 shares of CANB Series B Preferred Stock. On May 9, 2019, the Company issued 23,710 shares of CANB common stock to RedDiamond in exchange for the retirement of 55,263 shares of CANB Series B Preferred Stock. On June 7, 2019, the Company issued 10,726 shares of CANB common stock to RedDiamond in exchange for the retirement of 25,000 shares of CANB Series B Preferred Stock. On August 13, 2019, the Company issued 97,607 shares of CANB common stock to RedDiamond in exchange for the retirement of 227,590 shares of CANB Series B Preferred Stock. On December 16, 2019, the Company issued 35,666 shares of CANB common stock to RedDiamond as agreed for the early retirement of CANB Series B Preferred Stock converted in August 2019.

Common Stock

Common Stock	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Common Stock	NOTE 11 – Common Stock From January 4, 2019 to March 27, 2019, the Company issued aggregately 138,107 shares of CANB common stock to multiple investors pursuant to relative Stock Purchase Agreements dated on various dates, in exchange for total proceeds of $1,196,100. On January 14, 2019, the Company issued 25,000 shares of CANB common stock to Hudilab, Inc. (“HUDI”), pursuant to a License and Acquisition Agreement for purchase of the technology owned by HUDI. From January 18, 2019 to March 17, 2019, the Company issued aggregately 82,000 shares of CANB common stock to multiple consultants for services rendered. From January 19, 2019 to March 27, 2019, the Company issued aggregately 3,893 shares of CANB common stock to employee and officers of the Company pursuant to employee agreement and in satisfaction of accrued compensation for the quarter ended March 31, 2019. On February 5, 2019, the Company issued 6,667 shares to the owner of TZ Wholesale LLC, pursuant to a Memorandum of Understanding (the “MOU”) dated November 9, 2018. On February 20, 2019, the Company issued 3,333 shares of CANB common stock to owners of Seven Chakras pursuant to the Chakras Agreement dated January 31, 2019. From April 1, 2019 through June 30, 2019 the Company issued an aggregate of 51,706 shares of CANB Common Stock to multiple consultants for services rendered. From April 1, 2019 through June 30, 2019, the Company issued an aggregate of 13,916 shares of CANB Common Stock to members of the Advisory Board, Medical Advisory Board, and Sports Advisory Board for services rendered. From April 1, 2019 through June 30, 2019, the Company issued an aggregate of 4,615 shares of Common Stock under the terms of executive employment agreements. From April 1, 2019 through June 30, 2019, the Company issued an aggregate of 86,207 shares of CANB shares under the terms of the Stock Purchase Agreements for total proceeds of $750,000. From July 1, 2019 through September 30, 2019, the Company issued an aggregate of 18,061 shares of CANB Common Stock to multiple consultants for services rendered. From July 1, 2019 through September 30, 2019, the Company issued an aggregate of 18,333 shares of CANB Common Stock to members of the Advisory Board, Medical Advisory Board, and Sports Advisory Board for services rendered. From July 1, 2019 through September 30, 2019, the Company issued an aggregate of 16,000 shares of Common Stock under the terms of executive employment agreements. From July 1, 2019 through September 30, 2019, the Company issued an aggregate of 155,241 shares of CANB shares under the terms of the Stock Purchase Agreements for total proceeds of $1,350,600. From July 1, 2019 through September 30, 2019, the Company issued an aggregate of 40,247 shares of CANB shares under the terms of the Joint Venture Agreement. From October 1, 2019 through December 31, 2019, the Company issued an aggregate of 122,258 shares of CANB Common Stock to multiple consultants for services rendered. From October 1, 2019 through December 31, 2019, the Company issued an aggregate of 14,167 shares of CANB Common Stock to members of the Advisory Board, Medical Advisory Board, and Sports Advisory Board for services rendered. From October 1, 2019 through December 31, 2019, the Company issued an aggregate of 5,000 shares of Common Stock under the terms of executive employment agreements. From October 1, 2019 through December 31, 2019, the Company issued an aggregate of 125,000 shares of CANB Common Stock under the terms of an inventory purchase agreement for total proceeds of $487,500. From January 1, 2020 through March 31, 2020, the Company issued an aggregate of 27,500 shares of CANB Common Stock to multiple consultants for services rendered. From January 1, 2020 through March 31, 2020, the company issued an aggregate of 31,335 shares of CANB Common Stock to members of the Advisory Board, Medical Advisory Board, and Sports Advisory Board for services rendered. From January 1, 2020 through March 31, 2020, the Company issued an aggregate of 20,000 shares of CANB Common Stock to First Fire Global Opportunities Fund, LLC for a commitment fee pursuant to a junior convertible promissory note purchase agreement. From January 1, 2020 through March 31, 2020, the Company issued an aggregate of 99,508 shares of CANB Common Stock to FirstFire Global Opportunities Fund, LLC for returnable shares pursuant to a junior convertible promissory note purchase agreement. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 111,734 shares of CANB Common Stock to multiple consultants for services rendered. From April 1, 2020 through June 30, 2020, the company issued an aggregate of 20,319 shares of CANB Common Stock to members of the Advisory Board, Medical Advisory Board, and Sports Advisory Board for services rendered. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 30,000 shares of CANB Common Stock to an employee for services rendered. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 185,000 shares of CANB Common Stock to SRAX, Inc. according to a platform access agreement. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 50,000 shares of CANB Common Stock to Mediiusa Group, Inc. according to a hemp processing use agreement. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 24,545 shares of CANB Common Stock to Labrys Fund, L.P. for a commitment fee pursuant to a junior convertible promissory note purchase agreement. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 118,000 shares of CANB Common Stock to Labrys Fund, L.P. for returnable shares pursuant to a junior convertible promissory note purchase agreement. From April 1, 2020 through June 30, 2020, the Company issued an aggregate of 20,000 shares of CANB Common Stock to Eagle Equities, LLC for a commitment fee pursuant to a junior convertible promissory note purchase agreement.

Stock Options and Warrants

Stock Options and Warrants	6 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock Options and Warrants	NOTE 12 – Stock Options and Warrants A summary of stock options and warrants activity follows: Shares of Common Stock Exercisable Into Stock Options Warrants Total Balance, December 31, 2019 20,167 7,492 27,659 Granted in 2019 56,667 - 56,667 Cancelled in 2019 (167 ) - (167 ) Exercised in 2019 - - - Balance, December 31, 2019 76,667 7,492 84,159 Granted in Q1 & Q2 2020 - - - Cancelled in Q1 & Q2 2020 - - - Exercised in Q1 & Q2 2020 - - - Balance, June 30, 2020 76,667 7,492 84,159 Issued and outstanding stock options as of June 30, 2020 consist of: Year Number Outstanding Exercise Year of Granted And Exercisable Price Expiration 2018 20,000 $ 0.3 2023 2019 56,667 $ 0.3 2022 76,667 On June 11, 2018, the Company granted 10,000 options of CANB common stock to Carl Dilley, a former director of the Company, in exchange for the retirement of a total of 10,000 shares of CANB common stock from Carl Dilley. The options are exercisable for the purchase of one share of the Registrant’s Common Stock at an exercise price of $0.30 per share. The Options are fully vested and are exercisable as of the Grant Date and all shall expire June 11, 2023. The value of the Stock Options ($84,000) were calculated using the Black Scholes option pricing model and the following assumptions: (i) $8.40 share price, (ii) 5 years term, (iii) 262.00% expected volatility, (iv) 2.80% risk free interest rate and the difference between this value and the fair value of retired shares was expensed in the quarterly period ended June 30, 2018. On October 21, 2018, the Company granted 10,000 options of CANB common stock to Stanley L. Teeple, an officer and Director of the Company. The options are exercisable for the purchase of one share of the Registrant’s Common Stock at an exercise price of $0.30 per share. The Options are fully vested and are exercisable as of the Grant Date and all shall expire October 1, 2023. The values of the Stock Options ($118,200) were calculated using the Black Scholes option pricing model and the following assumptions: (i) $11.82 share price, (ii) 5 years term, (iii) 221.96% expected volatility, (iv) 3.05% risk free interest rate and the fair value of options was expensed in the quarterly period ended December 31, 2018 On September 9, 2019, the Company granted 26,667 options of CANB common stock to Johnny Mack, a former officer of the Company. The options are exercisable for the purchase of one share of the Registrant’s Common Stock at an exercise price of $0.30 per share. The Options are fully vested and are exercisable as of the Grant Date and all shall expire September 9, 2022. The values of the Stock Options ($192,000) were calculated using the Black Scholes option pricing model and the following assumptions: (i) $7.20 share price, (ii) 3 years term, (iii) 242% expected volatility, (iv) 1.46% risk free interest rate and the fair value of options was expensed in the quarterly period ended September 30, 2019. On October 15, 2019, the Company granted 10,000 options of CANB common stock each to Frederick Alger Boyer, Jr., Ronald A. Silver and James F. Murphy, directors of the Company. The options are exercisable for the purchase of one share of the Registrant’s Common Stock at an exercise price of $0.30 per share. The Options are fully vested and are exercisable as of the Grant Date and all shall expire October 15, 2022. The values of the Stock Options ($63,000 each) were calculated using the Black Scholes option pricing model and the following assumptions: (i) $6.30 share price, (ii) 3 years term, (iii) 242% expected volatility, (iv) 1.60% risk free interest rate and the fair value of options was expensed in the quarterly period ended December 31, 2019. Issued and outstanding warrants as of June 30, 2020 consist of: Year Number Outstanding Exercise Year of Granted And Exercisable Price Expiration 2010 825 $ 300 2020 2018 6,667 $ 13.034 (a) 2023 Total 7,492 (a) 110% of the closing price of the Company’s common stock on the date that the Holder funds the full purchase price of the Note.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 13 – Income Taxes No provisions for income taxes were recorded for the periods presented since the Company incurred net losses in those periods. The provisions for (benefits from) income taxes differ from the amounts determined by applying the U.S. Federal income tax rate of 21% to pretax income (loss) as follows: Six Month Ended June 30, 2020 2019 Expected income tax (benefit) at 21% $ (486.157 ) $ (246,228 ) Non-deductible stock-based compensation 204,915 173,921 Increase in deferred income tax assets valuation allowance 281,242 72,307 Provision for (benefit from) income taxes $ - $ - Deferred income tax assets consist of: June 30, December 31, 2020 2019 Net operating loss carryforward $ 1,581,410 $ 1,300,168 Valuation allowance (1,581,410 ) (1,300,168 ) Net $ - $ - Based on management’s present assessment, the Company has not yet determined it to be more likely than not that a deferred income tax asset of $1,581,410 attributable to the future utilization of the $7,530,518 net operating loss carryforward as of June 30, 2020 will be realized. Accordingly, the Company has maintained a 100% allowance against the deferred income tax asset in the financial statements at June 30, 2020. The Company will continue to review this valuation allowance and make adjustments as appropriate. The net operating loss carryforward expires in years 2025, 2026, 2027, 2028, 2029, 2030, 2031, 2032, 2033, 2034, 2035, 2036, 2037, 2038, 2039 and 2040 in the amount of $1,369, $518,390, $594,905, $686,775, $159,141, $151,874, $135,096, $166,911, $311,890, $25,511, $338,345, $381,638, $499,288, $716,858, $1,503,282, and $1,339,245, respectively. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. The Company’s U.S. Federal and state income tax returns prior to 2015 are closed and management continually evaluates expiring statutes of limitations, audits, proposed settlements, changes in tax law and new authoritative rulings. The statute of limitations on the 2015 tax year returns expired in September 2019. The Company recognizes interest and penalties associated with uncertain tax positions as part of the income tax provision and would include accrued interest and penalties with the related tax liability in the consolidated balance sheets. There were no interest or penalties paid during 2020 and 2019.

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Segment Information	NOTE 14 – Segment Information The Company has one reportable segment: Durable Equipment Products. The accounting policies of the segment described above are the same as those described in Summary of Significant Accounting Policies in Note 3. The Company evaluates the performance of the Durable Equipment Products segment based on income (loss) before income taxes, which includes interest income. Durable Equipment Products Three months ended March 31, 2020 Revenue from external customers 443,742 Revenue from other segments - Segment profit 259,489 Segment assets 2,259,478 Six months ended June 30, 2020 Revenue from external customers 527,942 Revenue from other segments - Segment profit 278,337 Segment assets 2,228,575 Three Months Six Months Total profit for reportable segment $ 18,848 $ 279,190 Other income (expense) - net - (853 ) Income before income taxes $ 18,848 $ 278,337

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 15 – Commitments and Contingencies Employment Agreements On October 3, 2017, the Company executed an Executive Employment Agreement with Marco Alfonsi (“Alfonsi”) for Alfonsi to serve as the Company’s chief executive officer and interim chief financial officer and secretary for cash compensation of $10,000 per month. Pursuant to the agreement, the Company issued a share of CANB Series A Preferred Stock to Alfonsi on October 4, 2017. Alfonsi may terminate his employment upon 30 days written notice to the Company. The Company may terminate Alfonsi’s employment upon written notice to Alfonsi by a vote of the Board of Directors. At October 21, 2018, this former agreement was terminated due to the execution of a new Employment Agreement with Marco Alfonsi for Alfonsi to serve as the Company’s chief executive officer and chairman of the board for cash compensation of $15,000 per month. Pursuant to the new agreement, three of the eight previously issued shares of CANB Series A Preferred Stock were returned to the Company and converted into 30,000,000 common shares. Alfonsi may terminate his employment upon 30 days written notice to the Company. The new agreement has an initial term of four years and can be terminated upon the resignation or death of Mr. Alfonsi, and also can be terminated by the Company due to the failure or neglect of Mr. Alfonsi to perform his duties, or due to the misconduct of Mr. Alfonsi in connection with the performance. On February 12, 2018, the Company executed an Executive Service Agreement (“Posel Agreement”) with David Posel. The Posel Agreement provides that Mr. Posel services as the Company’s Chief Operating Officer for a term of 4 years. The Posel Agreement also provides for compensation to Mr. Posel of $5,000 cash per month and the issuance of 1 share of Series A Preferred Stock at the inception of the Posel Agreement. The Posel Agreement can be terminated upon the resignation or death of Mr. Posel, and also can be terminated by the Company due to the failure or neglect of Mr. Posel to perform his duties, or due to the misconduct of Mr. Posel in connection with the performance. On February 12, 2018, 1 share of CANB Series A Preferred Stock were issued to Mr. Posel. Since execution of the Posel Agreement, Mr. Posel has been re-assigned to COO for Pure Health Products, the Company’s subsidiary. On February 16, 2018, the Company executed an Executive Service Agreement (“Holtmeyer Agreement”) with Andrew W. Holtmeyer. The Holtmeyer Agreement provides that Mr. Holtmeyer serves as the Company’s Executive Vice President Business for a term of 3 years. The Holtmeyer Agreement also provides for compensation to Mr. Holtmeyer of $10,000 cash per month and the issuance of 3, 2 and 1 share of Series A Preferred Stock at the beginning of each year. The Holtmeyer Agreement can be terminated upon the resignation or death of Mr. Holtmeyer, and also can be terminated by the Company due to the failure or neglect of Mr. Holtmeyer to perform his duties, or due to the misconduct of Mr. Holtmeyer in connection with the performance. At December 29, 2018, this Holtmeyer Agreement was terminated due to the execution of a new Employment Agreement with Andrew W Holtmeyer. The second agreement provides that Mr. Holtmeyer serves as the Company’s Executive Vice President Business for a term of 4 years. The second agreement also provides for compensation to Mr. Holtmeyer of $15,000 cash per month and the issuance of 829 shares of common stock upon signing of the agreement. Effective April 1, 2020, Mr. Holtmeyer’s compensation was changed to a straight commission on sales and collection based upon his efforts in lieu of any base compensation. He also received no further Company benefits but does retain his previously issued five shares of Series Preferred A Stock. On October 15, 2018, the Company executed an Employment Agreement (“Teeple Agreement”) with Stanley L. Teeple. The Teeple Agreement provides that Mr. Teeple services as the Company’s Chief Financial Officer and Secretary for a term of 4 years. The Teeple Agreement also provides for compensation to Mr. Teeple of $15,000 cash per month and the issuance of 1 share of Series A Preferred Stock proportionately vesting over four years beginning December 31, 2018 upon execution of the Teeple Agreement. The Teeple Agreement can be terminated upon the resignation or death of Mr. Teeple, and also can be terminated by the Company due to the failure or neglect of Mr. Teeple to perform his duties, or due to the misconduct of Mr. Teeple in connection with the performance. In May 2019 Mr. Teeple was granted an additional 3 shares of Series A Preferred. On December 28, 2018, the Company executed an Employment Agreement (“Ferro Agreement”) with Pasquale Ferro for Mr. Ferro to serve as Pure Health Products’ president for cash compensation of $15,000 per month and the total issuance of 5 share of Series A Preferred Stock proportionately vesting at the beginning of each year for a term of 4 years. Mr. Ferro may terminate his employment upon 30 days written notice to the Company. The Ferro Agreement has an initial term of four years and can be terminated upon the resignation or death of Mr. Ferro, and also can be terminated by the Company due to the failure or neglect of Mr. Ferro to perform his duties, or due to the misconduct of Mr. Ferro in connection with the performance. Effective September 6, 2019 (the “Effective Date”), Can B̅ Corp. (the “Company” or “CANB”) approved the appointment of Johnny J. Mack (“Mack”) as its President and Chief Operating Officer. Mack had been serving as the Company’s interim COO. The Company and Mack have entered into a new Employee Services Agreement (the “Mack Agreement”) to memorialize the terms of the foregoing. In consideration for Mack’s services, Mack would (i) receive a base salary of $15,000 per month, subject to increase after each yearly anniversary of the Agreement, (ii) be eligible to receive annual cash or stock bonuses, (iii) be entitled to four weeks’ vacation time and five paid days for illness in accordance with the Company’s policies, and (iv) receive a total of 106,667 options (“Mack Options”) to purchase shares of the Company’s common stock, with 26,667 Mack Options vesting on the effective date and additional tranches of 26,667 Mack Options vesting on each of the first, second, and third anniversaries of the Effective Date, assuming Mack’s continued employment. Each Option is exercisable at a price of $0.30 per share. The Company also agreed to hold harmless and indemnify Mack as authorized or permitted by law and the Company’s governing documents, as the same may be amended from time to time, except for acts constituting negligence or willful misconduct by Mack. The Company agreed to pay Mack a severance in the event the Mack Agreement is terminated by the Company without cause or by Mack for “good reason” or by reason of Mack’s death or disability. On October 4, 2019 Mack resigned from all of his officer and director positions and the Company settled his termination for payment of all accrued expenses, payout of all accrued time and base compensation of $13,315 and retention of his already earned 26,667 options. Mr. Mack has left the Company. In addition, on October 10 th Consulting Agreements On July 15, 2020, we engaged an advisor to provide consulting services under an Investor Relations and Advisory Agreement (the “Advisory Agreement”). Pursuant to the Advisory Agreement, we agreed to pay the Consulting Firm a restricted common stock monthly fee of $5,000 per month for the initial 3 months., $6,250 per month for months 4-6., $7,500 per month for month 7 and after. At CANB’s option, the monthly fee may be payable in part or in whole in cash. Monthly Fee, such amount shall be paid via issuance of restricted common shares of CANB. The shares are to be issued in the name of Tysadco Partners. The number of common shares earned each month shall be calculated and issued on a quarterly basis prior to each 90-day period and based on the value at the closing price on the last day of the preceding period. All common shares earned by the Consultant pursuant to this Agreement shall be issued by CANB on a quarterly basis. CT shall not have registration rights, and the shares may be sold subject to Rule 144. On December 8, 2019, the Company executed a Consulting Agreement with Seacore Capital, Inc. (“Seacore”) for Seacore to serve as the Company’s consultant for stock compensation of a total of 8,333 restricted shares each quarter from 4 th rd Lease Agreements On December 1, 2014, Prosperity entered into a lease agreement with KLAM, Inc. for office space in Hicksville, New York for an initial term of one year commencing December 1, 2014. The lease provides for monthly rentals of $2,500 and provides Prosperity an option to renew the lease after the initial term. The Company has continued to occupy this space after November 30, 2015 under a month to month arrangement at $2,500 per month. This lease was terminated in January 2019. On September 11, 2015, the Company executed a lease agreement with an unrelated third party for office space in Hicksville, New York for a term of 37 months. The lease provides for monthly rentals of $2,922 for lease year 1, $3,009 for lease year 2, and $3,100 for lease year 3. The lease also provides for additional rent based on increases in base year operating expenses and real estate taxes. On August 6, 2018, the Company renewed the lease agreement for a term of 36 months starting November 1, 2018. The lease provides for monthly rentals of $3,193 for lease year 1, $3,289 for lease year 2, and $3,388 for lease year 3. In October 2019, the Company modified and extended the lease agreement for a term of 30 months starting November 1, 2019. The lease provides for monthly rentals of $3,807.05 for year 1 and $3,921.26 for the remaining eighteen months. The original $100,681 right-of-use asset and $90,591 lease liability was adjusted to $103,260 with the modification. The Company leases office space in numerous medical facilities under month-to-month agreements. Rent expense for the period ended June 30, 2020 and 2019 was $121,652 and $12,344, respectively. At June 30, 2020, the future minimum lease payments under non-cancellable operating leases were: Year ended December 31, 2020 $ 23,071 Year ended December 31, 2021 47,055 Year ended December 31, 2022 15,685 Total $ 85,811 The lease liability of $78,727 at June 30, 2020 as presented in the Consolidated Balance Sheet represents the discounted (at our 10% estimated incremental borrowing rate) value of the future lease payments of 85,811 at June 30, 2020. Major Customers For the six months ended June 30, 2020, there were no customers that accounted for more than 10% of total revenues. For the six months ended June 30, 2020, there were no customer accounted for more than 10% of total revenues.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 16 – Related Party Transactions LI Accounting Associates, LLC (LIA), an entity controlled by a relative of the Managing Member PHP, is a vendor of CANB. At June 30, 2020, CANB has an account payable due to LIA totaling $6,600. For the six months ended June 30, 2020, CANB had expenses to LIA of $42,600. During the six months ended June 30, 2020, we had products and service sales to related parties totaling $0.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 17 – Subsequent Events In accordance with FASB ASC 855, Subsequent Events, the Company has evaluated subsequent events through August 14, 2020, the date on which these consolidated financial statements were available to be issued. There were material subsequent events that required recognition or additional disclosure in these consolidated financial statements as follows: By written consent and after careful review by the majority of the Shareholders of Can B Corp., the Company Shareholders approved an Incentive Stock Option Plan to be administered at the direction of the Board of Directors, and also approved a Certificate of Amendment to the Certificate of Designation for the Company’s Preferred Series A stock. The Company executed an exchange agreement whereby shares of Iconic Brands, Inc. held by the Company were exchanged for shares of stock in the Company held by Iconic Brands, Inc. The valuation of the respective shares were deemed to be an economic equal value exchange. The Company’s Form A-1 was qualified on August 7, 2020.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Principles of Consolidation	(a) Principles of Consolidation The consolidated financial statements include the accounts of CANB and its wholly-owned subsidiaries, Pure Health Products, Duramed, Prosperity Radical Tactical and Green Grow Farms. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	(b) Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Fair Value of Financial Instruments	(c) Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, notes receivable, notes and loans payable, accounts payable, and accrued expenses payable. Except for the noncurrent note receivable, the fair value of these financial instruments approximate their carrying amounts reported in the balance sheets due to the short term maturity of these instruments. Based on comparable instruments with similar terms, the fair value of the noncurrent note receivable approximates its carrying value. Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
Cash and Cash Equivalents	(d) Cash and Cash Equivalents The Company considers all liquid investments purchased with a maturity of three months or less to be cash equivalents.
Accounts Receivable	(e) Accounts receivable Accounts receivable are presented in the balance sheet net of the allowance for doubtful accounts. Accounts receivable are written off when they are determined to be uncollectible. The allowance for doubtful accounts is estimated based on the Company’s historical losses, the existing economic conditions in the industry, and the financial stability of its customers. Bad debt expense was $131,985 and $0 for the periods ended June 30, 2020 and 2019.
Inventory	(f) Inventory Inventories consist of raw materials and finished goods and are stated at the lower of cost or net realizable value. Cost is principally determined using the first-in, first-out (FIFO) method.
Prepaid Expenses	(g) Prepaid expenses Prepaid expenses include stock-based officer, employee and consulting compensation of $1,836,523 and $3,226,390 at June 30, 2020 and 2019, respectively. The Company’s policy is to record stock-based compensation as prepaids and expense over the term of employment and consulting agreements.
Property and Equipment, Net	(h) Property and Equipment, Net Property and equipment, net, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs are charged to operations as incurred.
Intangible Assets, Net	(i) Intangible Assets, Net Intangible assets, net, are stated at cost less accumulated amortization. Amortization is calculated using the straight-line method over the estimated economic lives of the respective assets.
Marketable Securities	(j) Marketable Securities Marketable securities are recorded at fair value with unrealized gains and losses included in income. The Company has classified its investments in 1,000,000 shares of Iconic Brands, Inc. as trading securities.
Goodwill	(k) Goodwill The Company does not amortize goodwill, but instead tests for impairment at least annually. When conducting the annual impairment test for goodwill, the Company compares the estimated fair value of a reporting unit containing goodwill to its carrying value. If the estimated fair value of the reporting unit is determined to be less than its carrying value, goodwill is reduced, and an impairment loss is recorded.
Long-lived Assets	(l) Long-lived Assets The Company reviews long-lived assets held and used, intangible assets with finite useful lives and assets held for sale for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset is compared to the asset’s carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds the fair value.
Revenue Recognition	(m) Revenue Recognition The Company recognizes revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which requires that five basic steps be followed to recognize revenue: (1) a legally enforceable contract that meets criterial standards as to composition and substance is identified; (2) performance obligations relating to provision of goods or services to the customer are identified; (3) the transaction price, with consideration given to any variable, noncash, or other relevant consideration, is determined; (4) the transaction price is allocated to the performance obligations; and (5) revenue is recognized when control of goods or services is transferred to the customer with consideration given, whether that control happens over time or not. Determination of criteria (3) and (4) are based on our management’s judgments regarding the fixed nature of the selling prices of the products and services delivered and the collectability of those amounts. Private Label Customers, Global CBD, LLC and TZ Wholesale, are wholesale distributors of the Company’s product, under their own wholesale private label brand. The products are made to Company specifications and shipped directly to the wholesaler. The pricing is predicated upon a volume discount negotiated at the time of the placement of the orders. Product is produced and labeled in the Washington manufacturing facility and shipped directly to the Private Label customer who re-distributes to their retail and other customers. The products are fully paid when shipped. Revenue from product sales is recognized when an order has been obtained, the price is fixed and determinable, the product is shipped, title has transferred, and collectability is reasonably assured. The Company’s Duramed Division provides a sam® Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients’ needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient who signs a rental form, for a 35 day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The insurance company pays the invoice, or a negotiated amount via arbitration, and that revenue is reported as revenue when invoiced to the insurance carrier. The collected amount is reconciled with the invoice amount on a daily basis.
Cost of Product Sales	(n) Cost of Product Sales The cost of product sale is the total cost incurred to obtain a sale and the cost of the goods sold, and the Company’s policy is to recognize it in the same manner as, and in conjunction with, revenue recognition. Cost of product sale primarily consisted of the costs directly attributable to revenue recognized and includes expenses related to the production, packaging and labeling of our CBD products.
Stock-Based Compensation	(o) Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation – Stock Compensation” (“ASC718”) and ASC 505-50, “Equity – Based Payments to Non-Employees.” In addition to requiring supplemental disclosures, ASC 718 addresses the accounting for share-based payment transactions in which a company receives goods or services in exchange for (a) equity instruments of the company or (b) liabilities that are based on the fair value of the company’s equity instruments or that may be settled by the issuance of such equity instruments. ASC 718 focuses primarily on accounting for transactions in which a company obtains employee services in share-based payment transactions. In accordance with ASC 505-50, the Company determines the fair value of the stock-based payment as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. If the fair value of the equity instruments issued is used, it is measured using the stock price and other measurement assumptions as of the earlier of either (1) the date at which a commitment for performance by the counterparty to earn the equity instrument is reached, or (2) the date at which the counterparty’s performance is complete. Options and warrants The fair value of stock options and warrants is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year: Risk-Free Interest Rate. We utilized the U.S. Treasury yield curve in effect at the time of grant with a term consistent with the expected term of our awards. Expected Volatility. We calculate the expected volatility based on a volatility index of peer companies as we did not have sufficient historical market information to estimate the volatility of our own stock. Dividend Yield. We have not declared a dividend on its common stock since its inception and have no intentions of declaring a dividend in the foreseeable future and therefore used a dividend yield of zero. Expected Term. The expected term of options granted represents the period of time that options are expected to be outstanding. We estimated the expected term of stock options by using the simplified method. For warrants, the expected term represents the actual term of the warrant. Forfeitures. Estimates of option forfeitures are based on our experience. We will adjust our estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods.
Advertising	(p) Advertising Advertising costs are expensed as incurred and amounted to $260,035 and $153,762 for the periods ended June 30, 2020 and 2019, respectively.
Research and Development	(q) Research and Development Research and development costs are expensed as incurred. In the period ended June 30, 2020 and 2019, the Company spent $25,000 and $70,000 in research and development which was expenses as spent, respectively.
Income Taxes	(r) Income Taxes Income taxes are accounted for under the assets and liability method. Current income taxes are provided in accordance with the laws of the respective taxing authorities. Deferred income taxes are provided for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is not more likely than not that some portion or all of the deferred tax assets will be realized. The Company has adopted the provisions required by the Income Taxes topic of the FASB Accounting Standards Codification. The Codification Topic requires the recognition of potential liabilities as a result of management’s acceptance of potentially uncertain positions for income tax treatment on a “more-likely-than-not” probability of an assessment upon examination by a respective taxing authority. The Company believes that it has not taken any uncertain tax positions and thus has not recorded any liability.
Net Income (Loss) Per Common Share	(s) Net Income (Loss) per Common Share Basic net income (loss) per common share is computed on the basis of the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is computed on the basis of the weighted average number of common shares and dilutive securities (such as stock options and convertible securities) outstanding. Dilutive securities having an anti-dilutive effect on diluted net income (loss) per share are excluded from the calculation. For the periods presented, the diluted net loss per share calculation excluded the effect of Series B preferred stocks and stock options outstanding (see Notes 10, 11 and 12).
Reverse Stock-Split	(t) Reverse Stock-Split On March 2, 2020, the Company filed an amendment to its Articles of Incorporation with the Florida Secretary of State to effect a 300-to-1 reverse stock split of its issued and outstanding, but not authorized, shares of Common Stock, as reported in the Company’s definitive Schedule 14C filed with the Securities and Exchange Commission on December 13, 2019. All disclosures of common shares and per common share data in the accompanying financial statements and related notes reflect the reverse stock split for all periods presented.
Recent Accounting Pronouncements	(u) Recent Accounting Pronouncements In 2016, the FASB issued ASU 2016-2 (Topic 842) which establishes a new lease accounting model for lessees. Under the new guidance, lessees will be required to recognize right of use assets and liabilities for most leases having terms of 12 months or more. Effective January 1, 2019, we adopted this new accounting guidance using the effective date transition method, which permits entities to apply the new lease standards using a modified retrospective transition approach at the date of adoption.
Basis of Presentation	(v) Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six-month period ended June 30, 2020 are not necessarily indicative of the results that may be expected for the year ended December 31, 2020.
Reclassifications	(w) Reclassifications Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation. These reclassification adjustments had no effect on the Company’s previously reported net income.

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of: June 30, December 31, Raw materials $ 359,213 $ 708,239 Finished goods 14,620 76,258 Total $ 373,833 $ 784,497

Notes Receivable (Tables)

Notes Receivable (Tables)	6 Months Ended
	Jun. 30, 2020
Receivables [Abstract]
Schedule of Notes Receivable	Notes receivable consist of: June 30, December 31, Note receivable dated November 30, 2015 from Stock Market Manager, Inc, interest at 3% per annum due November 30, 2020 $ 19,389 $ 19,389 Note receivable dated February 8, 2019 from an employee, weekly installments of $1,200 with interest at 8% per annum. 2,898 4,879 Note receivable dated March 3, 2020 from an employee, weekly installments of $125 with interest at 0% per annum. 1,500 - Total 23,787 24,268 Current portion of notes receivable (23,787 ) (24,268 ) Noncurrent portion of notes receivable $ - $ -

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property and Equipment, net, consist of: June 30, December 31, 2020 2019 Furniture & Fixtures $ 21,724 $ 19,018 Office Equipment 12,378 12,378 Manufacturing Equipment 363,798 355,016 Medical Equipment 783,782 783,782 Leasehold Improvements 26,902 21,603 Total 1,208,584 1,191,797 Accumulated depreciation (178,065 ) (116,555 ) Net $ 1,030,519 $ 1,075,242

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	6 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets, net, consist of: June 30, December 31, 2020 2019 Video conferencing software acquired by Prosperity in December 2009 $ 30,000 $ 30,000 Enterprise and audit software acquired by Prosperity in April 2008 20,000 20,000 Patent costs incurred by WRAP 6,880 6,880 Hemp license and technology 1,000,000 1,000,000 CBD technology 198,655 198,655 Platform account contract 131,812 - Hemp processing use 69,375 - Other 3,548 3,548 Total 1,460,270 1,259,083 Accumulated amortization and Impairment (479,679 ) (202,521 ) Net $ 980,591 $ 1,056,562

Marketable Securities (Tables)

Marketable Securities (Tables)	6 Months Ended
	Jun. 30, 2020
Cash and Cash Equivalents [Abstract]
Schedule of Marketable Securities	Marketable securities consist of: June 30, December 31, Marketable securities, at cost $ 600,000 $ - Unrealized losses (50,000 ) - Total marketable securities at fair value $ 550,000 $ -

Notes and Loans Payable (Tables

Notes and Loans Payable (Tables)	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Schedule of Notes and Loans Payable	Notes and loans payable consist of: June 30, December 31, Note payable to brother of Marco Alfonsi, Chief Executive Officer of the Company, interest at 10% per annum, due August 22, 2016 (now past due) $ 5,000 $ 5,000 Note payable to FirstFire Global Opportunities Fund, LLC, net of original issue discount of $44,654, due September 1, 2020. 550,000 - Loan payable to Pasquale Ferro, interest at 12% per annum, due December 2020. 153,000 30,000 Note payable to Labrys Fund, LP, net of original issue discount of $21,041, due October 21, 2020. 225,000 - Note payable to EMA Financial, LLC, net of original issue discount of $10,522, due June 17, 2021. 115,000 - Note payable to Eagle Equities, LLC, net of original issue discount of $27,645, due June 17, 2021. 220,000 - Note payable to U.S. Small Business Administration (PPP), interest at 1% per annum. The note matures in May 2022. Payments are deferred for six months. 194,940 - Note payable to U.S. Small Business Administration (EIDL), interest at 3.75% per annum. The note matures in June 2050. Payments are deferred for twelve months. 159,900 - Total Notes and Loans Payable 1,622,840 35,000 Less: Unamortized Finance Cost (103,862 ) - Total Notes and Loans Payable - Net 1,518,978 35,000 Less: Current Portion (1,164,138 ) (35,000 ) Long-term Portion $ 354,840 $ -

Stock Options and Warrants (Tab

Stock Options and Warrants (Tables)	6 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Summary of Stock Options and Warrants Activity	A summary of stock options and warrants activity follows: Shares of Common Stock Exercisable Into Stock Options Warrants Total Balance, December 31, 2019 20,167 7,492 27,659 Granted in 2019 56,667 - 56,667 Cancelled in 2019 (167 ) - (167 ) Exercised in 2019 - - - Balance, December 31, 2019 76,667 7,492 84,159 Granted in Q1 & Q2 2020 - - - Cancelled in Q1 & Q2 2020 - - - Exercised in Q1 & Q2 2020 - - - Balance, June 30, 2020 76,667 7,492 84,159
Schedule of Issued and Outstanding Stock Options	Issued and outstanding stock options as of June 30, 2020 consist of: Year Number Outstanding Exercise Year of Granted And Exercisable Price Expiration 2018 20,000 $ 0.3 2023 2019 56,667 $ 0.3 2022 76,667
Schedule of Issued and Outstanding Warrants	Issued and outstanding warrants as of June 30, 2020 consist of: Year Number Outstanding Exercise Year of Granted And Exercisable Price Expiration 2010 825 $ 300 2020 2018 6,667 $ 13.034 (a) 2023 Total 7,492 (a) 110% of the closing price of the Company’s common stock on the date that the Holder funds the full purchase price of the Note.

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Schedule of Provisions for (Benefits from) Income Taxes	The provisions for (benefits from) income taxes differ from the amounts determined by applying the U.S. Federal income tax rate of 21% to pretax income (loss) as follows: Six Month Ended June 30, 2020 2019 Expected income tax (benefit) at 21% $ (486.157 ) $ (246,228 ) Non-deductible stock-based compensation 204,915 173,921 Increase in deferred income tax assets valuation allowance 281,242 72,307 Provision for (benefit from) income taxes $ - $ -
Schedule of Deferred Income Tax Assets	Deferred income tax assets consist of: June 30, December 31, 2020 2019 Net operating loss carryforward $ 1,581,410 $ 1,300,168 Valuation allowance (1,581,410 ) (1,300,168 ) Net $ - $ -

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	The Company evaluates the performance of the Durable Equipment Products segment based on income (loss) before income taxes, which includes interest income. Durable Equipment Products Three months ended March 31, 2020 Revenue from external customers 443,742 Revenue from other segments - Segment profit 259,489 Segment assets 2,259,478 Six months ended June 30, 2020 Revenue from external customers 527,942 Revenue from other segments - Segment profit 278,337 Segment assets 2,228,575 Three Months Six Months Total profit for reportable segment $ 18,848 $ 279,190 Other income (expense) - net - (853 ) Income before income taxes $ 18,848 $ 278,337

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Leases	At June 30, 2020, the future minimum lease payments under non-cancellable operating leases were: Year ended December 31, 2020 $ 23,071 Year ended December 31, 2021 47,055 Year ended December 31, 2022 15,685 Total $ 85,811

Organization and Description _2

Organization and Description of Business (Details Narrative)	Mar. 06, 2020	Mar. 02, 2020	Jun. 04, 2013	Dec. 27, 2010	Jun. 30, 2020	Dec. 28, 2018	Jan. 05, 2015
State of incorporated					Florida
Entity date of incorporation					Oct. 11, 2005
Stockholders' equity, stock split				10 for 1 forward stock split
Stockholders' equity, reverse stock split	300:1 reverse split	300-to-1 reverse stock split	1 for 10 reverse stock split		300:1 reverse stock split rounding
Prosperity Systems, Inc [Member]
Business acquisition, percentage							100.00%
Pure Health Products, LLC [Member]
Business acquisition, percentage						100.00%

Going Concern Uncertainty (Deta

Going Concern Uncertainty (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 390,201		$ 390,201		$ 46,540
Working capital	2,005,234		2,005,234
Net income loss	$ 1,188,425	$ 1,437,491	$ 2,315,032	$ 2,610,005

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Mar. 06, 2020	Mar. 02, 2020	Jun. 04, 2013	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Accounting Policies [Abstract]
Bad debt expense						$ 131,985
Prepaid expenses				$ 1,836,523	$ 3,226,390	$ 1,836,523	3,226,390
Investment shares in trading securities						1,000,000
Advertising costs				$ 141,205	$ 127,374	$ 260,035	153,762
Research and development cost						$ 25,000	$ 70,000
Stockholders equity, Reverse stock split	300:1 reverse split	300-to-1 reverse stock split	1 for 10 reverse stock split			300:1 reverse stock split rounding

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 359,213	$ 708,239
Finished goods	14,620	76,258
Total	$ 373,833	$ 784,497

Notes Receivable - Schedule of

Notes Receivable - Schedule of Notes Receivable (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Note receivable, Total	$ 23,787	$ 24,268
Current portion of notes receivable	(23,787)	(24,268)
Noncurrent portion of notes receivable
Employee One [Member]
Note receivable, Total	2,898	4,879
Employee Two [Member]
Note receivable, Total	1,500
Stock Market Manager, Inc [Member]
Note receivable, Total	$ 19,389	$ 19,389

Notes Receivable - Schedule o_2

Notes Receivable - Schedule of Notes Receivable (Details) (Parenthetical) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Employee One [Member]
Note receivable interest rate	8.00%	8.00%
Installments	$ 1,200	$ 1,200
Employee Two [Member]
Note receivable interest rate	0.00%	0.00%
Installments	$ 125	$ 125
Stock Market Manager, Inc [Member]
Notes receivable due date	Nov. 30, 2020	Nov. 30, 2020
Note receivable interest rate	3.00%	3.00%

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Furniture & Fixtures	$ 21,724	$ 19,018
Office Equipment	12,378	12,378
Manufacturing Equipment	363,798	355,016
Medical Equipment	783,782	783,782
Leasehold Improvements	26,902	21,603
Total	1,208,584	1,191,797
Accumulated depreciation	(178,065)	(116,555)
Net	$ 1,030,519	$ 1,075,242

Intangible Assets, Net (Details

Intangible Assets, Net (Details Narrative) - USD ($)	Jun. 23, 2020	Feb. 20, 2019	Jan. 14, 2019	Jun. 30, 2020	Jun. 30, 2019
Cash payments					$ 50,000
Intangible assets, net				$ 0
Mediiusa Group, Inc [Member]
Shares issued to acquire assets	50,000
Shares issued to acquire assets, value	$ 69,375
SRAX, Inc [Member]
Shares issued to acquire assets	185,000
Shares issued to acquire assets, value	$ 131,812
License and Acquisition Agreement [Member] | Hudilab, Inc. [Member]
Shares issued to acquire assets			25,000
Shares issued to acquire assets, value			$ 131,625
Asset Purchase Agreement [Member] | Seven Chakras, LLC [Member]
Shares issued to acquire assets		3,333
Shares issued to acquire assets, value		$ 17,030
Cash payments		$ 50,000

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Intangible Assets and Goodwill (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Patent costs incurred by WRAP	$ 6,880	$ 6,880
Hemp license and technology	1,000,000	1,000,000
CBD technology	198,655	198,655
Platform account contract	131,812
Hemp processing use	69,375
Other	3,548	3,548
Total	1,460,270	1,259,083
Accumulated amortization and Impairment	(479,679)	(202,521)
Net	980,591	1,056,562
Video Conferencing Software Acquired by Prosperity in December 2009 [Member]
Software acquired	30,000	30,000
Enterprise and Audit Software Acquired by Prosperity in April 2008 [Member]
Software acquired	$ 20,000	$ 20,000

Marketable Securities - Schedul

Marketable Securities - Schedule of Marketable Securities (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Cash and Cash Equivalents [Abstract]
Marketable securities, at cost	$ 600,000
Unrealized losses	(50,000)
Total marketable securities at fair value	$ 550,000

Notes and Loans Payable - Sched

Notes and Loans Payable - Schedule of Notes and Loans Payable (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Total Notes and Loans Payable	$ 1,622,840	$ 35,000
Less: Unamortized Finance Cost	(103,862)
Total Notes and Loans Payable - Net	1,164,138	35,000
Less: Current Portion	(1,164,138)	(35,000)
Long-term Portion	354,840
Note Payable One [Member]
Total Notes and Loans Payable	5,000	5,000
Note Payable Two [Member]
Total Notes and Loans Payable	550,000
Loan Payable One [Member]
Total Notes and Loans Payable	153,000	30,000
Note Payable Three [Member]
Total Notes and Loans Payable	225,000
Note Payable Four [Member]
Total Notes and Loans Payable	115,000
Note Payable Five [Member]
Total Notes and Loans Payable	220,000
Note Payable Six [Member]
Total Notes and Loans Payable	194,940
Note Payable Seven [Member]
Total Notes and Loans Payable	$ 159,900

Notes and Loans Payable - Sch_2

Notes and Loans Payable - Schedule of Notes and Loans Payable (Details) (Parenthetical) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Notes Payable One [Member]
Debt instrument, interest rate	10.00%	10.00%
Debt instrument, maturity date	Aug. 22, 2016	Aug. 22, 2016
Note Payable Two [Member]
Debt instrument, maturity date	Sep. 1, 2020	Sep. 1, 2020
Original discount amount	$ 44,654	$ 44,654
Loan Payable One [Member]
Debt instrument, interest rate	12.00%	12.00%
Debt instrument, maturity date	Dec. 31, 2020	Dec. 31, 2020
Note Payable Three [Member]
Debt instrument, maturity date	Oct. 21, 2020
Original discount amount	$ 21,041
Note Payable Four [Member]
Debt instrument, maturity date	Jun. 17, 2021
Original discount amount	$ 10,522
Note Payable Five [Member]
Debt instrument, maturity date	Jun. 17, 2021
Original discount amount	$ 27,645
Note Payable Six [Member]
Debt instrument, interest rate	1.00%
Debt instrument, maturity date	May 31, 2022
Note Payable Seven [Member]
Debt instrument, interest rate	3.75%
Debt instrument, maturity date	Jun. 30, 2050

Preferred Stock (Details Narrat

Preferred Stock (Details Narrative) - USD ($)

Dec. 16, 2019

Aug. 13, 2019

Jun. 07, 2019

May 28, 2019

May 09, 2019

May 01, 2019

Apr. 26, 2019

Jan. 28, 2019

Oct. 15, 2018

May 31, 2019

Mar. 12, 2019

Mar. 31, 2020

Dec. 31, 2019

Jun. 30, 2020

Jun. 30, 2019

Fair value of preferred stock issuance

$ 1,946,100

Preferred Stock C [Member]

Number of convertible shares

25,000

Common Stock [Member]

Stock issued during period, shares, issued for services

159,737

Shares issued during the period

224,314

Fair value of preferred stock issuance

$ 1,946,100

Common Stock [Member] | RedDiamond Partners LLC [Member]

Shares issued during the period

35,666

97,607

10,726

23,710

8,581

6,436

67,405

Consultant [Member]

Stock issued during period, shares, issued for services

27,500

122,258

Consultant [Member] | Common Stock [Member]

Stock issued during period, shares, issued for services

33,333

Series A Preferred Stock [Member]

Number of convertible shares

33,334

Number of voting rights per share

66,666

Preferred stock, voting rights

Each share of Series A Preferred Stock is convertible into 33,334 shares of CANB common stock and is entitled to 66,666 votes.

Series A Preferred Stock [Member] | Consultant [Member]

Stock issued in exchange for retirement of shares

1

Series A Preferred Stock [Member] | Stanley L. Teeple [Member] | Employment Agreement [Member]

Stock issued during period, shares, issued for services

1

3

Shares issued during the period

3

Fair value of preferred stock issuance

$ 1,203,000

Amortized vesting period

4 years

Series B Preferred Stock [Member]

Preferred stock, voting rights

The shares of Series B Preferred Stock have no voting rights.

Dividend, description

Each share of Series B Preferred Stock has the first preference to dividends, distributions and payments upon liquidation, dissolution and winding-up of the Company, and is entitled to an accrued cumulative but not compounding dividend at the rate of 5% per annum whether or not declared. After six months of the issuance date, such share and any accrued but unpaid dividends can be converted into common stock at the conversion price which is the lower of (i) $0.0101; or (ii) the lower of the dollar volume weighted average price of CANB common stock on the trading day prior to the conversion day or the dollar volume weighted average price of CANB common stock on the conversion day. The shares of Series B Preferred Stock have no voting rights.

Preferred stock, dividend rate, percentage

5.00%

Series B Preferred Stock [Member] | RedDiamond Partners LLC [Member]

Stock issued in exchange for retirement of shares

227,590

25,000

55,263

20,000

15,000

157,105

Common Stock (Details Narrative

Common Stock (Details Narrative) - USD ($)

Feb. 20, 2019

Feb. 05, 2019

Jan. 28, 2019

Jan. 14, 2019

Mar. 27, 2019

Mar. 17, 2019

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2019

Sep. 30, 2019

Jun. 30, 2019

Mar. 27, 2019

Jun. 30, 2020

Jun. 30, 2019

Stock issued during the period, value

$ 1,946,100

Proceeds from issuance of common stock

$ 1,946,100

TZ Wholesale LLC [Member]

Stock issued during period, shares, issued for services

6,667

Common Stock [Member]

Stock issued during the period

224,314

Stock issued during the period, value

$ 1,946,100

Stock issued during period, shares, issued for services

159,737

Consultant [Member]

Stock issued during period, shares, issued for services

111,734

18,061

51,706

Members of Advisory Board, Medical Advisory Board, and Sports Advisory Board [Member]

Stock issued during period, shares, issued for services

20,319

18,333

13,916

Stock Purchase Agreement [Member]

Stock issued during the period

155,241

86,207

Proceeds from issuance of common stock

$ 1,350,600

$ 750,000

License and Acquisition Agreement [Member] | Hudilab, Inc. [Member]

Shares issued to acquire assets

25,000

Asset Purchase Agreement [Member] | Seven Chakras, LLC [Member]

Shares issued to acquire assets

3,333

Executive Employment Agreements [Member]

Stock issued during period, shares, issued for services

30,000

5,000

16,000

4,615

Joint Venture Agreement [Member]

Stock issued during the period

40,247

Investor Purchase Agreement [Member]

Stock issued during period, shares, issued for services

125,000

Proceeds from issuance of common stock

$ 487,500

Junior Convertible Promissory Note Purchase Agreement [Member] | First Fire Global Opportunities Fund, LLC [Member]

Stock issued during period, shares, issued for services

20,000

Junior Convertible Promissory Note Purchase Agreement [Member] | Labrys Fund, L.P [Member]

Stock issued during the period

24,545

Junior Convertible Promissory Note Purchase Agreement [Member] | Eagle Equities, LLC [Member]

Stock issued during the period

20,000

Junior Convertible Promissory Note Purchase Agreement [Member] | First Fire Global Opportunities Fund, LLC [Member]

Stock issued during period, shares, issued for services

99,508

Platform access agreement [Member] | SRAX, Inc [Member]

Stock issued during the period

185,000

hemp processing use agreement [Member] | Mediiusa Group, Inc [Member]

Stock issued during the period

50,000

Returnable share Junior Convertible Promissory Note Purchase Agreement [Member] | Labrys Fund, L.P [Member]

Stock issued during the period

118,000

Multiple Investors [Member] | Common Stock [Member]

Stock issued during period, shares, issued for services

82,000

Multiple Investors [Member] | Stock Purchase Agreement [Member]

Stock issued during the period

138,107

Stock issued during the period, value

$ 1,196,100

Employees and Officers [Member] | Employee Agreement [Member] | Common Stock [Member]

Stock issued during period, shares, issued for services

3,893

Consultant [Member]

Stock issued during period, shares, issued for services

27,500

122,258

Consultant [Member] | Common Stock [Member]

Stock issued during period, shares, issued for services

33,333

Medical Advisory Board, and Sports Advisory Board [Member]

Stock issued during period, shares, issued for services

31,335

14,167

Stock Options and Warrants (Det

Stock Options and Warrants (Details Narrative) - USD ($)	Oct. 15, 2019	Sep. 09, 2019	Oct. 21, 2018	Jun. 11, 2018	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018	Jun. 30, 2018
Stock options, fair value						$ 192,000	$ 118,200	$ 84,000
Stock options, share price						$ 7.20	$ 11.82	$ 8.40
Stock options, expected term						3 years	5 years	5 years
Stock options, expected volatility rate						242.00%	221.96%	262.00%
stock options, risk-free interest rate						1.46%	3.05%	2.80%
Carl Dilley [Member]
Granted options				10,000
Stock issued in exchange for retirement of shares				10,000
Options exercisable for purchase of share				1
Exercisable price per share				$ 0.30
Expiration date				Jun. 11, 2023
Stanley L. Teeple [Member]
Granted options			10,000
Exercisable price per share			$ 0.30
Expiration date			Oct. 1, 2023
Johnny Mack [Member]
Granted options		26,667
Options exercisable for purchase of share		1
Exercisable price per share		$ 0.30
Expiration date		Sep. 9, 2022
Frederick Alger Boyer [Member]
Granted options	10,000
Options exercisable for purchase of share	1
Exercisable price per share	$ 0.30
Expiration date	Oct. 15, 2022
Stock options, fair value					$ 63,000
Stock options, share price					$ 6.30
Stock options, expected term					3 years
Stock options, expected volatility rate					242.00%
stock options, risk-free interest rate					1.60%
Jr., Ronald A. Silver [Member]
Granted options	10,000
Options exercisable for purchase of share	1
Exercisable price per share	$ 0.30
Expiration date	Oct. 15, 2022
Stock options, fair value					$ 63,000
Stock options, share price					$ 6.30
Stock options, expected term					3 years
Stock options, expected volatility rate					242.00%
stock options, risk-free interest rate					1.60%
James F. Murphy [Member]
Granted options	10,000
Options exercisable for purchase of share	1
Exercisable price per share	$ 0.30
Expiration date	Oct. 15, 2022
Stock options, fair value					$ 63,000
Stock options, share price					$ 6.30
Stock options, expected term					3 years
Stock options, expected volatility rate					242.00%
stock options, risk-free interest rate					1.60%

Stock Options and Warrants - Su

Stock Options and Warrants - Summary of Stock Options and Warrants Activity (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Beginning balance	84,159	27,659
Granted		56,667
Cancelled		(167)
Exercised
Ending balance	84,159	84,159
Warrant [Member]
Beginning balance	7,492	7,492
Granted
Cancelled
Exercised
Ending balance	7,492	7,492
Stock Option [Member]
Beginning balance	76.667	20,167
Granted		56,667
Cancelled		(167)
Exercised
Ending balance	76,667	76.667

Stock Options and Warrants - Sc

Stock Options and Warrants - Schedule of Issued and Outstanding Stock Options (Details)	6 Months Ended
	Jun. 30, 2020$ / sharesshares
Number of Options Outstanding and Exercisable, Number	76,667
Stock Option 2018 [Member]
Number of Options Outstanding and Exercisable, Number	20,000
Number of Options Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares	$ 0.3
Number of Options Outstanding and Exercisable, Expiration year	2023
Stock Option 2019 [Member]
Number of Options Outstanding and Exercisable, Number	56,667
Number of Options Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares	$ 0.3
Number of Options Outstanding and Exercisable, Expiration year	2022

Stock Options and Warrants - _2

Stock Options and Warrants - Schedule of Issued and Outstanding Warrants (Details)	6 Months Ended
	Jun. 30, 2020$ / sharesshares
Warrant [Member]
Number of Warrants Outstanding and Exercisable, Number	7,492
2010 Warrant [Member]
Number of Warrants Outstanding and Exercisable, Number	825
Number of Warrants Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares	$ 300
Number of Warrants Outstanding and Exercisable, Expiration year	2020
2018 Warrant [Member]
Number of Warrants Outstanding and Exercisable, Number	6,667
Number of Warrants Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares	$ 13.034	[1]
Number of Warrants Outstanding and Exercisable, Expiration year	2023
[1]	110% of the closing price of the Company's common stock on the date that the Holder funds the full purchase price of the Note.

Stock Options and Warrants - _3

Stock Options and Warrants - Schedule of Issued and Outstanding Warrants (Details) (Parenthetical)	6 Months Ended
	Jun. 30, 2020
2018 Warrant [Member]
Percentage of closing price of common stock funding purchase price	110.00%

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal income tax rate	21.00%	21.00%
Deferred income tax asset, valuation allowance	$ 1,581,410	$ 1,581,410	$ 1,300,168
Operating loss carryforwards		7,530,518
Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent	100.00%
Operating loss carryforwards, 2025		1,369
Operating loss carryforwards, 2026		518,390
Operating loss carryforwards, 2027		594,905
Operating loss carryforwards, 2028		686,775
Operating loss carryforwards, 2029		159,141
Operating loss carryforwards, 2030		151,874
Operating loss carryforwards, 2031		135,096
Operating loss carryforwards, 2032		166,911
Operating loss carryforwards, 2033		311,890
Operating loss carryforwards, 2034		25,511
Operating loss carryforwards, 2035		338,345
Operating loss carryforwards, 2036		381,638
Operating loss carryforwards, 2037		499,288
Operating loss carryforwards, 2038		716,858
Operating loss carryforwards, 2039		1,503,282
Operating loss carryforwards, 2040		1,339,245
Income tax examination, penalties and interest expense

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provisions for (Benefits from) Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Expected income tax (benefit) at 21%			$ (486,157)	$ (246,228)
Non-deductible stock-based compensation			204,915	173,921
Increase in deferred income tax assets valuation allowance			281,242	72,307
Provision for (benefit from) income taxes	$ 275		$ 1,225

Income Taxes - Schedule of Pr_2

Income Taxes - Schedule of Provisions for (Benefits from) Income Taxes (Details) (Parenthetical)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Federal income tax rate	21.00%	21.00%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Income Tax Assets (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 1,581,410	$ 1,300,168
Valuation Allowance	(1,581,410)	(1,300,168)	$ (1,581,410)
Net

Segment Information (Details Na

Segment Information (Details Narrative)	6 Months Ended
	Jun. 30, 2020Integer
Segment Reporting [Abstract]
Number of reportable segments	1

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Revenue from external customers	$ 205,084		$ 633,579	$ 774,791	$ 1,150,739
Segment assets	7,188,614			7,188,614		$ 6,930,870
Income before income taxes	(1,188,150)		$ (1,437,491)	(2,313,807)	$ (2,610,005)
Durable Equipment Products [Member]
Revenue from external customers		$ 443,742		527,942
Revenue from other segments
Segment profit		259,489		278,337
Segment assets	2,228,575	$ 2,259,478		2,228,575
Total profit for reportable segment	18,848			279,190
Other income (expense) - net				(853)
Income before income taxes	$ 18,848			$ 278,337

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)

Jul. 15, 2020

Dec. 08, 2019

Oct. 10, 2019

Oct. 04, 2019

Sep. 06, 2019

Dec. 29, 2018

Dec. 29, 2018

Dec. 28, 2018

Nov. 12, 2018

Oct. 21, 2018

Oct. 15, 2018

Feb. 16, 2018

Feb. 12, 2018

Oct. 03, 2017

Dec. 01, 2014

May 31, 2019

Jun. 30, 2020

Jun. 30, 2019

Jun. 30, 2020

Jun. 30, 2019

Dec. 31, 2019

Oct. 31, 2019

Aug. 06, 2018

Sep. 11, 2015

Employee cash compensation per month

$ 382,082

$ 829,138

$ 1,020,755

$ 1,274,688

Professional fees

134,958

74,180

325,136

112,016

Rent expense

29,046

$ 484

121,652

$ 12,344

Monthly rentals for lease year 1

23,071

23,071

Monthly rentals for lease year 2

47,055

47,055

Monthly rentals for lease year 3

15,685

15,685

Operating lease, right-of-use asset

78,052

78,052

$ 96,980

Lease liability

78,727

$ 78,727

Estimated incremental borrowing rate

10.00%

Future lease payments

$ 85,811

$ 85,811

Sales Revenue, Net [Member] | No Customer [Member]

Concentration risk percentage

10.00%

Concentration risk, description

More than 10% of total revenues

Common Stock [Member]

Stock issued during period, shares, issued for services

159,737

Stanley L. Teeple [Member]

Granted options to purchase stock

10,000

Exercisable price per share

$ 0.30

Executive Employment Agreement [Member] | Marco [Member]

Employee cash compensation per month

$ 10,000

New Employment Agreement [Member] | Marco [Member]

Employee cash compensation per month

$ 15,000

New Employment Agreement [Member] | Marco [Member] | Common Stock [Member]

Number of shares issued as a result of conversion

30,000,000

New Employment Agreement [Member] | Andrew W Holtmeyer [Member]

Employee cash compensation per month

$ 15,000

Employment term

4 years

New Employment Agreement [Member] | Andrew W Holtmeyer [Member] | Common Stock [Member]

Stock issued during period, shares, issued for services

829

Executive Service Agreement [Member] | David Posel [Member]

Employee cash compensation per month

$ 5,000

Employment term

4 years

Executive Service Agreement [Member] | David Posel [Member] | Series A Preferred Stock [Member]

Stock issued during period, shares, issued for services

1

Executive Service Agreement [Member] | Andrew W Holtmeyer [Member]

Employee cash compensation per month

$ 10,000

Employment term

3 years

Executive Service Agreement [Member] | Andrew W Holtmeyer [Member] | Series A Preferred Stock [Member]

Issuance of shares, description

3, 2 and 1 share of Series A Preferred Stock at the beginning of each year

Employment Agreement [Member] | Stanley L. Teeple [Member]

Employee cash compensation per month

$ 15,000

Employment term

4 years

Employment Agreement [Member] | Stanley L. Teeple [Member] | Series A Preferred Stock [Member]

Stock issued during period, shares, issued for services

1

3

Employment Agreement [Member] | Pasquale Ferro [Member]

Employee cash compensation per month

$ 15,000

Vesting term

4 years

Employment Agreement [Member] | Pasquale Ferro [Member] | Series A Preferred Stock [Member]

Stock issued during period, shares, issued for services

5

New Employment Services Agreement [Member] | Johnny J. Mack [Member]

Employee cash compensation per month

$ 15,000

Granted options to purchase stock

106,667

Number of stock options vesting

26,667

Exercisable price per share

$ 0.30

Accrued employee benefits

$ 13,315

Retention of options

26,667

New Employment Services Agreement [Member] | Johnny J. Mack [Member] | First Anniversary [Member]

Number of stock options vesting

26,667

New Employment Services Agreement [Member] | Johnny J. Mack [Member] | Second Anniversary [Member]

Number of stock options vesting

26,667

New Employment Services Agreement [Member] | Johnny J. Mack [Member] | Third Anniversary [Member]

Number of stock options vesting

26,667

Employee Agreement [Member] | Philip Scala [Member]

Employee cash compensation per month

$ 2,500

Employment term

3 years

Granted options to purchase stock

1,667

Shares issued price per share

$ 0.30

Investor Relations and Advisory Agreement [Member] | Initial 3 Months [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Professional fees

$ 5,000

Investor Relations and Advisory Agreement [Member] | 4-6 Months [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Professional fees

6,250

Investor Relations and Advisory Agreement [Member] | 7 Months and After [Member] | Subsequent Event [Member] | Restricted Stock [Member]

Professional fees

$ 7,500

Consulting Agreement [Member] | Restricted Stock [Member] | Seacore Capital Inc. [Member]

Stock issued during period, shares, issued for services

8,333

Lease Agreement [Member] | KLAM, Inc [Member]

Rent expense

$ 2,500

Lease Agreement [Member] | Unrelated Third Party [Member]

Initial term of lease

37 months

Monthly rentals for lease year 1

$ 2,922

Monthly rentals for lease year 2

3,009

Monthly rentals for lease year 3

$ 3,100

Renewed Lease Agreement [Member] | Unrelated Third Party [Member]

Monthly rentals for lease year 1

$ 3,807

$ 3,193

Monthly rentals for lease year 2

$ 3,921

3,289

Monthly rentals for lease year 3

$ 3,388

Renewal term of lease

30 months

36 months

Operating lease, right-of-use asset

$ 100,681

Lease liability

90,591

Adjusted modification of lease liabilities

$ 103,260

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Leases (Details)	Jun. 30, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
Year ended December 31, 2020	$ 23,071
Year ended December 31, 2021	47,055
Year ended December 31, 2022	15,685
Total	$ 85,811

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	6 Months Ended
	Jun. 30, 2020USD ($)
Products sales to related parties	$ 0
LI Accounting Associates, LLC [Member]
Related party expense	42,600
LI Accounting Associates, LLC [Member] | Accounts Payable [Member]
Due to related parties	$ 6,600